Ingrezza and Restless leg syndrome - a phase IV clinical study of FDA data

Summary:

Restless leg syndrome is found among people who take Ingrezza, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Ingrezza and have Restless leg syndrome. It is created by eHealthMe based on reports of 21,750 people who have side effects when taking Ingrezza from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 13, 2023

21,750 people reported to have side effects when taking Ingrezza.
Among them, 104 people (0.48%) have Restless leg syndrome.

What is Ingrezza?

Ingrezza has active ingredients of valbenazine tosylate. eHealthMe is studying from 21,759 Ingrezza users for its effectiveness, alternative drugs and more.

What is Restless leg syndrome?

Restless leg syndrome (a powerful urge to move your legs) is found to be associated with 2,384 drugs and 1,764 conditions by eHealthMe.

Number of Ingrezza and Restless leg syndrome reports submitted per year:

Could Ingrezza cause Restless leg syndrome?

* Approximation only. Some reports may have incomplete information.

Do you take Ingrezza and have Restless leg syndrome?

Check whether Restless leg syndrome is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Restless leg syndrome and when was it recovered:

Restless leg syndrome in Ingrezza

Expand to all the drugs that have ingredients of valbenazine tosylate:

Restless leg syndrome and drugs with ingredients of valbenazine tosylate

Alternative drugs to, pros and cons of Ingrezza:

Ingrezza (21,759 reports)

Common Ingrezza side effects:

Browse all side effects of Ingrezza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Restless leg syndrome treatments and more:

Restless leg syndrome (44,952 reports)

COVID vaccines that are related to Restless leg syndrome:

Common drugs associated with Restless leg syndrome:

All the drugs that are associated with Restless leg syndrome:

Restless leg syndrome (2,384 drugs)

Common conditions associated with Restless leg syndrome:

Depression: 1,613 reports
Multiple sclerosis: 1,068 reports
Pain: 978 reports
Osteoporosis: 948 reports
High blood pressure: 779 reports

All the conditions that are associated with Restless leg syndrome:

Restless leg syndrome (1,764 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on valbenazine tosylate (the active ingredients of Ingrezza) and Ingrezza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.